SRDX - サ―モディクス （Surmodics Inc.）SRDXのニュース
Surmodics stock surges 10% on FDA feedback for drug-coated balloon filing 2023/03/28 16:23:16 Seeking Alpha
Surmodics (SRDX) stock rose after the company said it received feedback from the FDA for an application seeking approval of SurVeil. Read more here
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil Drug-Coated Balloon 2023/03/28 13:25:00 Wallstreet:Online
Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that it has received formal feedback from the Food and Drug Administration (FDA; the Agency) related to its proposed approach to submit an amended premarket approval (PMA) application for the SurVeil drug-coated balloon (DCB). Following the receipt
Trading Surmodics $SRDX With Integrated Risk Controls 2023/03/12 11:45:00 Stock Traders Daily
Trading Surmodics SRDX With Integrated Risk Controls
Surmodics to Participate in Upcoming Investor Conferences in March 2023/03/08 13:30:00 Business Wire
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #InVitroDiagnostic--Management will make a presentation to the investment community at the Oppenheimer Healthcare Conference on Wednesday, March 15, at 9:40 a.m. CT.
Surmodics downgraded at Needham on uncertainty over drug-coated balloon 2023/02/13 17:29:22 Seeking Alpha
Surmodics, Inc. (SRDX) lost sharply on Monday after Needham downgraded it to Hold from Buy, citing uncertain prospects for its drug-coated balloon SurVeil. Read the full story here.
Surmodics, Inc. (SRDX) Q4 2022 Earnings Call Transcript 2022/11/13 01:45:03 Seeking Alpha
Surmodics, Inc. (NASDAQ:NASDAQ:SRDX) Q4 2022 Earnings Conference Call November 09, 2022, 10:00 ET Company Participants Gary Maharaj - CEO, President & Director Timothy Arens - SVP,…
Surmodics, Inc. 2022 Q4 - Results - Earnings Call Presentation 2022/11/13 01:44:38 Seeking Alpha
The following slide deck was published by Surmodics, Inc.
Surmodics Non-GAAP EPS of -$0.26 beats by $0.19, revenue of $25.99M beats by $1.9M 2022/11/09 12:46:53 Seeking Alpha
Surmodics press release (SRDX): Q4 Non-GAAP EPS of -$0.26 beats by $0.19.Revenue of $25.99M (+8.4% Y/Y) beats by $1.9M.Guidance: Surmodics expects fiscal year 2023 total revenue…
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance 2022/11/09 12:00:00 Business Wire
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #SRDX--Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces the Fiscal Year 2023 Financial Guidance
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th 2022/10/28 11:30:00 Business Wire
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
Surmodics Non-GAAP EPS of -$0.13, revenue of $23M; reaffirms full year guidance 2022/02/03 12:39:17 Seeking Alpha
Surmodics press release (SRDX): FQ1 Non-GAAP EPS of -$0.13.Revenue of $23M (+3.1% Y/Y).Surmodics expects fiscal year 2022 revenue to range from $97 million to $101 million vs
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by New York State Teachers Retirement System 2021/12/23 09:22:47 Transcript Daily
New York State Teachers Retirement System reduced its position in Surmodics, Inc. (NASDAQ:SRDX) by 1.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,326 shares of the companys stock after selling 500 shares during the quarter. New York []
Surmodics (NASDAQ:SRDX) Shares Gap Up to $44.84 2021/12/09 09:22:41 Transcript Daily
Shares of Surmodics, Inc. (NASDAQ:SRDX) gapped up before the market opened on Tuesday . The stock had previously closed at $44.84, but opened at $47.67. Surmodics shares last traded at $45.99, with a volume of 2 shares. Separately, Needham & Company LLC dropped their price objective on Surmodics from $76.00 to $70.00 and set a []
Assenagon Asset Management S.A. Has $5.76 Million Stock Position in Surmodics, Inc. (NASDAQ:SRDX) 2021/12/06 11:08:43 Dakota Financial News
Assenagon Asset Management S.A. lowered its stake in Surmodics, Inc. (NASDAQ:SRDX) by 2.1% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 103,586 shares of the companys stock after selling 2,230 shares during the period. Assenagon Asset Management S.A. owned approximately 0.75% of Surmodics worth []
Insider Selling: Surmodics, Inc. (NASDAQ:SRDX) Director Sells 3,475 Shares of Stock 2021/11/29 22:24:42 Transcript Daily
Surmodics, Inc. (NASDAQ:SRDX) Director David Dantzker sold 3,475 shares of Surmodics stock in a transaction on Wednesday, November 24th. The stock was sold at an average price of $47.01, for a total transaction of $163,359.75. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Shares of SRDX []